Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections

Clinical Infectious Diseases

Volumn 24, Issue 2, 1997, Pages 235-249

  Rex, John H ^a   Pfaller, Michael A ^a   Galgiani, John N ^a   Bartlett, Marilyn S ^a   Espinel Ingroff, Ana ^a   Ghannoum, Mahmoud A ^a   Lancaster, Michael ^a   Odds, Frank C ^a   Rinaldi, Michael G ^a   Walsh, Thomas J ^a   Barry, Arthur L ^a  

^a 6431 Fannin ^*

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA KRUSEI; CANDIDIASIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESISTANCE; HOST RESISTANCE; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0031052377     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.2.235     Document Type: Article

References (13)

1. Anaissie EJ, Bodey GP, Rinaldi MG. Emerging fungal pathogens. Eur J Clin Microbiol Infect Dis 1989;8:323-30.
2. Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(suppl 3B):86S-9S.
3. Fisher-Hoch SP, Hutwagner L. Opportunistic candidiasis: an epidemic of the 1980s. Clin Infect Dis 1995;21:897-904.
4. Galgiani JN, Reiser J, Brass C, Espinel-Ingroff A, Gordon MA, Kerkering TM. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob Agents Chemother 1987;31:1343-7.
5. Calhoun DL, Roberts GD, Galgiani JN, et al. Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. J Clin Microbiol 1986;23:298-301.
6. Rex JH, Pfaller MA, Rinaldi MG, Polak A, Galgiani JN. Antifungal susceptibility testing. Clin Microbiol Rev 1993;6:367-81.
7. Espinel-Ingroff A, Kerkering TM, Goldson PR, Shadomy S. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1991;29:1089-94.
8. Guinet R, Nerson D, De Closets F, et al. Collaborative evaluation in seven laboratories of a standardized micromethod for yeast susceptibility testing. J Clin Microbiol 1988;26:2307-12.
9. Shawar R, Paetznick V, Witte Z, Ensign LG, Anaissie E, LaRocco M. Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans. J Clin Microbiol 1992;30:1976-81.
10. Polak A. Multicenter-Studie zur Standardisierung der Empfindlichkeitsbestimmung von Pilzen gegen 5-Fluorcytosin und Amphotericin B. Mykosen 1987;30:306-314.
11. Espinel-Ingroff A, Kish CW Jr, Kerkering TM, et al. Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J Clin Microbiol 1992;30:3138-45.
12. Fromtling RA, Galgiani JN, Pfaller MA, et al. Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob Agents Chemother 1993;37:39-45.
13. Pfaller MA, Burmeister L, Bartlett MS, Rinaldi MG. Multicenter evaluation of four methods of yeast inoculum preparation. J Clin Microbiol 1988;26:1437-41.